The page is the record's research on the issuer — no analyst, no rating, no view. # BUKWANG PHARMACEUTICAL IND CO.,LTD (KOSPI: 003000) — research page As of 2026-11-06 · kr-cm-kg · record version 1 ## Identity and listing The issuer is BUKWANG PHARMACEUTICAL IND CO.,LTD, listed on KOSPI under ticker 003000, ISIN KR7003000007. The LEI is not on the record, as no GLEIF record is registered under 118-81-00450. The security type is Corporate, the segment is not on the record, the sector is 의약품 제조업, and the jurisdiction is South Korea (DART filer with a corporate registration number). The issuer is listed and not halted. ## The disclosure read The record holds 38 filings across 32 filing days in the window 2025-11-06 to 2026-11-06. The filings are 8 results, 23 corporate news, 3 AGM/EGM, 2 dividend and 2 regulatory filings. The median gap between filing days is 7 days. The latest filing is a results filing dated 2026-10-23, 14 days before the record date of 2026-11-06. On KOSPI the median cadence gap is 7.0 days, the median filings are 49.0, and the median latency is 7.0 days, across 832 issuers. In 의약품 제조업 the median cadence gap is 8.0 days, the median filings are 36, and the median latency is 8.5 days, across 107 issuers. The issuer's median cadence gap is below the sector median and at the exchange median. Its filing count is below both the exchange and sector medians. Its latency is above the exchange median and below the sector median. ## Auditor The auditor of record is 삼일회계법인. Its location is not on the record. The record does not carry auditor changes for this register. ## Events and halts The record does not carry listing, delisting, name change, domicile change or segment move events for this register, as no lifecycle type map is yet in place. The halt flag is not set, and the issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. The issuer has no sealed years. The live record began 2026-09-12. The store holds sealed years 2021 through 2026 for this market, which are not served as of a date; the as-of door answers not_sealed. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13 (identity.exchange) - https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd (identity.isin) - https://opendart.fss.or.kr/api/company.json?corp_code=00123718 (identity.jurisdiction) - https://mcp.kr-cm-kg.ai/events/KOSPI/003000 (the disclosure lines) - https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain (the halt flag) - https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260316001273 (the auditor) - https://mcp.kr-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.kr-cm-kg.ai/record/KOSPI/003000 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/kr/KOSPI/003000 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp